Nexgel (NXGL) Long-Term Deferred Tax (2021 - 2022)
Nexgel posted quarterly Long-Term Deferred Tax of $4.1 million for Q4 2022, up 23.66% year-on-year from $3.3 million in Q4 2021, and up 23.66% on a QoQ basis from $3.3 million in Q4 2021.
Nexgel (NXGL) has 2 years of Long-Term Deferred Tax data on file, last reported at $4.1 million in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Deferred Tax rose 23.66% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2022 stood at $4.1 million (up 23.66% YoY), and the FY2022 full-year result was $4.1 million, up 23.66% from the prior year.
- Long-Term Deferred Tax for Q4 2022 stood at $4.1 million, up from $3.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $4.1 million in Q4 2022 and bottomed at $3.3 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 3.33 Mn |